374 filings
Page 6 of 19
6-K
foaeu9b4 s8a3
14 Oct 10
Chief Executive Officer and Announces Annual Meeting
12:00am
6-K
qeanpdp94b7 j1p8by
1 Oct 10
Ym Biosciences to Present Poster on CYT387 at the European
12:00am
6-K
2vsbkbcycvs p9o
29 Sep 10
Ym Biosciences Licensee Pulmokine Awarded Nih
12:00am
40-F
emw x0f2wd8
24 Sep 10
Annual report (Canada)
12:00am
6-K
ybgl x3vbiyrsnh2756
24 Sep 10
Ym Biosciences Reports Fiscal Year End 2010 Operational and Financial Results
12:00am
6-K
ycj psh42nhv0
8 Sep 10
Ym Biosciences Announces Positive Results
12:00am
6-K
jxmev 2yu
10 Aug 10
Ym Biosciences Granted Orphan Drug Designation
12:00am
6-K
vas1b ufmo
5 Aug 10
Ym Biosciences Announces Conclusion of Phase I
12:00am
6-K
7bf1lbqhe
4 Jun 10
Ym Biosciences Appoints DR. Nick Glover
12:00am
SUPPL
8er0329bz
3 Jun 10
Supplemental materials (foreign)
12:00am
6-K
7zsvpi 5ew
3 Jun 10
Current report (foreign)
12:00am
6-K
43ndsa
27 May 10
Current report (foreign)
12:00am
UPLOAD
veu4wl pq
25 May 10
Letter from SEC
12:00am
6-K
weharnu9vn1ops7 ni
21 May 10
Ym Biosciences Announces Presentations on Global
12:00am
CORRESP
zmtfe3 g03cwqpelh
14 May 10
Correspondence with SEC
12:00am
6-K
wreg ov7mzh0c
13 May 10
Ym Biosciences Third Quarter 2010 Operational and Financial Results
12:00am
6-K
n151tl1
13 May 10
Current report (foreign)
12:00am
UPLOAD
64unw55863ue n8
7 May 10
Letter from SEC
12:00am
6-K
quqbl h931dg
27 Apr 10
Ym Biosciences Announces Controlled Equity Offering
12:00am
SUPPL
0xn42 d4u
26 Apr 10
Supplemental materials (foreign)
12:00am